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The database DisGeNet 2 currently lists over 1000 genes involved in the patho-biology of one or several cardiovascular diseases, collectively representing almost all known biological pathways. Nevertheless, for most cardiovascular diseases the detailed underlying molecular mechanisms remain only poorly understood and novel, more effective and more targeted therapies are sorely needed. In recent years, sophisticated technologies have emerged that allow us to investigate the molecular mechanisms of disease at an unprecedented level of detail. Both healthy and disease states can now be quantified at molecular resolution through diverse omics technologies, such as genome sequencing, transcriptome mapping, proteomics, metabolomics, etc. At the same time, it is becoming increasingly clear that a deeper understanding of these (patho-) physiological states requires not only a detailed characterization of its individual components (genes, proteins, metabolites, etc.), but also of their interactions. Indeed, biomolecules do not act in isolation, but are part of an intricate and tightly coordinated machinery of complex interactions, such as protein-protein, gene regulatory or signalling interactions. The exquisitely complex and highly dynamic nature of these networks poses a fundamental challenge to the traditional reductionist approach of biomedical research: Most likely, many disease phenomena cannot be fully understood by simple mechanistic models and also not be reversed by a single therapeutic target. 3 To unravel the emergent properties resulting from the complex interplay of many individual components, a more holistic, systems-oriented perspective is needed. The ambition of the young field of 'network medicine' is to provide such a perspective. Over the last decade, tools and concepts from network theory have successfully been applied to a broad range of diseases, from rare Mendelian disorders, 4 cancer, 5 or metabolic diseases, 6 virus-host interactions. 7 Several factors contributed to this success and widespread use: First and foremost, networks provide the most natural framework to describe and analyse the highly interconnected nature of the biomolecular machinery that forms the basis of virtually all biological processes. Systematic mapping efforts, based on high-throughput yeast two-hybrid 8 or mass spectrometry assays, 9 have produced unbiased genome-scale 'interactome' maps with sufficient coverage to investigate the impact of disease associated genetic perturbations on the network level. 10 An important general insight from such studies was that disease associated genes tend to aggregate in disease-specific network modules. This, in turn, can be used to design network-based algorithms for the identification of novel diseaseassociated genes and implicated pathways. It was also found that the effectivity of drugs can be related to the network distance of their targets to the respective disease module, 11 thus opening up new opportunities to select the most promising drug targets or to design multi-target drugs. 12 Networks also provide a platform for data analysis and interpretation beyond direct molecular interactions. In disease-disease networks, for example, diseases can be linked based on shared underlying molecular mechanisms, 13 or based on similar clinical manifestations. 14 Such networks can reveal surprising similarities between seemingly unrelated diseases, thereby helping elucidate the molecular mechanisms of frequent co-morbidities or informing the search for promising drug-repurposing opportunities. A particular strength of network approaches is that they uniquely combine powerful computational algorithms with intuitive visual representations. By inspecting network maps one can immediately identify important highly connected individual nodes or modules of strongly interconnected nodes. Arguably, the greatest power of networks lies in the fact that they provide a general purpose framework that can be used to describe and analyse any kind of system consisting of interrelated components. Indeed, it was the discovery that vastly different systems, such as the world wide web, collaboration networks, power grids or proteinprotein interaction networks, all share certain universal features that sparked the interest of scientists across many disciplines and kick-started the development of network science. 15 From mathematics and physics to biology, medicine, and social sciences, network concepts now pervade all areas of science, thus providing a common language to facilitate communication and knowledge transfer between and across disciplines. This may prove invaluable also in biomedical research, which is moving towards larger and more collaborative efforts that often involve a number of groups with different specialized expertise. Although the traditional boundaries between disciplines are still deeply ingrained in undergraduate education and university departments, crossing them will be vital for the success of the next generation of biomedical researchers. Being a physicist by training and now working in a molecular medicine research institute, I know from first-hand experience that this is not always easy. Yet, I can only recommend the young scientists of this summer school and elsewhere not to shy away from interdisciplinary and collaborative efforts, but to broaden their knowledge as much as possible. This will be of key importance not only to tackle the extraordinary challenges of present and future cardiovascular disease research, but it is also a deeply exciting and enjoyable experience, both intellectually and personally.
